PS-030 Safety assessment of protease inhibitors in the treatment of chronic hepatitis C virus infection
MG Rey, CA Conde, AC Otero, MLG Otero… - European Journal of …, 2014 - ejhp.bmj.com
Background The protease inhibitors (PI) boceprevir and telaprevir are associated with new
adverse events (AEs) which can reduce quality of life. Purpose To evaluate the safety of …
adverse events (AEs) which can reduce quality of life. Purpose To evaluate the safety of …
[PDF][PDF] Experiencia con colistina nebulizada en pacientes con bronquiectasias no fibrosis quística colonizadas por Pseudomonas aeruginosa.
MM López-Gil Otero… - Revista Española …, 2019 - pdfs.semanticscholar.org
Conclusiones. El tratamiento con colistina nebulizada durante 6 y 12 meses de
bronquiectasias no fibrosis quística, colonizadas/infectadas por P. aeruginosa, parece …
bronquiectasias no fibrosis quística, colonizadas/infectadas por P. aeruginosa, parece …
Drug administration in patients on enteral nutrition: the nasoenteral route versus the parenteral route
GP Corrales, RO Fernández… - Nutricion …, 2000 - pubmed.ncbi.nlm.nih.gov
The administration of medications through a nasoenteral tube or enterostomy is an
alternative to the parenteral route, as this is more comfortable, less aggressive for the …
alternative to the parenteral route, as this is more comfortable, less aggressive for the …
Drug administration through a tube to patients with enteral nutrition. Centralization in in pharmacy service
GP Corrales, RO Fernández… - Nutricion …, 1999 - pubmed.ncbi.nlm.nih.gov
The administration of a drug through the nasogastric tube, in most cases requires a
modification of the pharmaceutical form in order to achieve a good absorption and to avoid …
modification of the pharmaceutical form in order to achieve a good absorption and to avoid …
[CITATION][C] Nutrición parenteral en neonatos: individualización de la prescripción Parenteral nutrition in neonates: individualization of the prescription
NL Rivero, AC Guisán, AP Carreiro, MLG Durán…